We are live on ! Find out more
ANIX icon

Anixa Biosciences
ANIX

20 hedge funds and large institutions have $1.59M invested in Anixa Biosciences in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

844% more capital invested

Capital invested by funds: $169K → $1.59M (+$1.43M)

700% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 1

43% more funds holding

Funds holding: 14 → 20 (+6)

3.03% more ownership

Funds ownership: 0.98% → 4.01% (+3%)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

Holders
20
Holders Change
+6
Holders Change %
+42.86%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
2
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$396K
2
VF
Virtu Financial
New York
+$67.7K
3
TSS
Two Sigma Securities
New York
+$62.9K
4
Northern Trust
Northern Trust
Illinois
+$17.3K
5
CAM
Concorde Asset Management
Michigan
+$14.9K

Top Sellers

Rank Fund Capital Flow
1
BA
Bard Associates
Illinois
-$59K
2
Wells Fargo
Wells Fargo
California
-$1.78K
3
DIA
Denver Investment Advisors
Colorado
-$1.19K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$984K +$396K +359,933 +2,538%
VF
2
Virtu Financial
New York
$162K +$67.7K +61,536 New
TSS
3
Two Sigma Securities
New York
$150K +$62.9K +57,163 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$90K – – –
DIA
5
Denver Investment Advisors
Colorado
$46K -$1.19K -1,080 -6%
Northern Trust
6
Northern Trust
Illinois
$41K +$17.3K +15,701 New
CAM
7
Concorde Asset Management
Michigan
$36K +$14.9K +13,520 New
WS
8
Wedbush Securities
California
$34K +$14.3K +13,000 New
UBS Group
9
UBS Group
Switzerland
$21K +$564 +513 +7%
BlackRock
10
BlackRock
New York
$13K – – –
Morgan Stanley
11
Morgan Stanley
New York
$8K +$3.31K +3,012 New
IA
12
IFP Advisors
Florida
$3K – – –
JP Morgan Chase
13
JP Morgan Chase
New York
$3K – – –
Wells Fargo
14
Wells Fargo
California
$2K -$1.78K -1,616 -64%
EWM
15
Evercore Wealth Management
New York
$1K – – –
TDC
16
Thompson Davis & Co
Virginia
$1K +$275 +250 New
BA
17
Bard Associates
Illinois
– -$59K -51,200 Closed
Royal Bank of Canada
18
Royal Bank of Canada
Ontario, Canada
– +$10 +9 New

ANIX Hedge Fund Activity: Q3 2017 in Review

20 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q3 2017, worth a combined $1.59M — up 844% from $169K a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new ANIX positions and 1 closed out — a net gain of 7 holders — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Vanguard Group, adding an estimated $396K. The largest seller was Bard Associates, exiting entirely with an estimated $59K sold.

  • 20 institutional investors held Anixa Biosciences (ANIX) as of Q3 2017, up from 14 in Q2 2017.
  • Funds reported $1.59M of Anixa Biosciences stock for Q3 2017, up 844% quarter-over-quarter.
  • 8 funds opened new Anixa Biosciences positions in Q3 2017 and 1 closed out, a net change of +7 holders.
  • The largest Anixa Biosciences buyer in Q3 2017 was Vanguard Group, an estimated $396K added.
  • The largest Anixa Biosciences seller in Q3 2017 was Bard Associates, an estimated $59K sold.

Based on aggregated 13F filings for Q3 2017.